Targeting metabolism to protect fertility and healthy pregnancy with SGLT2 inhibitors and GLP-1RAs
{{output}}
Metabolic disease is a global health epidemic with detrimental effects on reproduction. The rising use of sodium glucose co-transporter 2 (SGLT2) inhibitors and glucagon-like peptide-1 receptor agonists (GLP-1RAs) have introduced new treatment options, however... ...
